ATLANTA, April 30, 2009 (GLOBE NEWSWIRE) -- Holzer Holzer & Fistel, LLC is investigating possible violations of federal securities law by Sequenom, Inc. ("Sequenom" or the "Company") (Nasdaq:SQNM). The investigation focuses on, among other things, whether Sequenom violated the Securities Exchange Act of 1934 by issuing materially false and misleading statements regarding the Company's Down syndrome test under development. Specifically, the investigation seeks to determine whether certain officers and directors of the Company failed to properly disclose that Sequenom employees mishandled test data and results regarding the Down syndrome test.
Shareholders who purchased Sequenom common stock between June 4, 2008 and April 29, 2009 with questions concerning their legal rights are encouraged to contact Holzer Holzer & Fistel, LLC and its attorneys Michael I. Fistel Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.
Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.